Take our user survey and make your voice heard.
world

U.S. gives full approval to antiviral remdesivir to treat Covid-19

2 Comments
By Ulrich Perrey

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© 2020 AFP

©2024 GPlusMedia Inc.

2 Comments
Login to comment

Another treatment option is always a good thing.

Not quite sure what this bit in the last line about private insurers paying so much more is all about. (?)

Gilead has set the price at $390 per vial in developed countries, or $2,340 for six vials used over the normal five-day course, though U.S. private insurers will pay $520 per vial.

0 ( +0 / -0 )

I agree. The virus will be less frightening when people have the ability to recover, or recover faster. So many companies are working on vaccines. What we need first is something, like a Tamiflu, that can be taken and reduces fatalities so catching it doesn't turn into a death sentence.

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites